ArticleThe European journal of health economics : HEPAC : health economics in prevention and care2020

Cost-effectiveness of midostaurin in the treatment of newly diagnosed FLT3-mutated acute myeloid leukemia in France.

Gabriel Tremblay et al.PubMed ↗Publisher ↗

No numbers read from the abstract.